DENTAL CERAMIC COLORING LIQUID HAVING MASKING PROPERTY
#902MICRONEEDLE PATCH AND PREPARATION METHOD THEREFOR
#903CLEAN SKIN CARE COMPOSITION
#904TOPICAL SKIN CARE COMPOSITION
#905 ✅ Patent 12,194,120 granted on 2025-01-14Skin care formulation containing silver nanoparticles
#906 ✅ Patent 12,239,723 granted on 2025-03-04Stabilized stannous compositions
#907Cosmetic Material Composition
#908COSMETIC COMPOSITION OF LOW OSMOLALITY
#909A FLUORIDE DENTIFRICE CONTAINING AN IODINE COMPONENT
#910PEROXIDE GEL COMPOSITIONS
#911COMPOSITION FOR KERATIN FIBERS
#912 ✅ Patent 11,857,656 granted on 2024-01-02Systems, methods, and kits for altering the color of the hair
#913Oral Compositions and Related Methods
#914PERSONAL CARE RINSE OFF COMPOSITION WITH COMPOSITE OPACIFIER PARTICLES
#915WHITE PIGMENT FOR COSMETICS, AND COSMETIC
#916POWDER-CONTAINING COMPOSITION
#917Hygiene Product Pod and Methods of Using Same
#918ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS
#919QUICK DISSOLVING, MILD, NATURAL AND SUSTAINABLE POWDER CLEANSING COMPOSITIONS FOR PERSONAL CARE FORMULATIONS
#920COMPOSITIONS COMPRISING COCAMIDOPROPYL BETAINE AND AT LEAST ONE FATTY ACID
#921COMPOSITION COMPRISING COMPOUND OF THIOPYRIDINONE TYPE AND POLYGLYCERYL-BASED EMULSIFIERS
#922 ✅ Patent 12,226,506 granted on 2025-02-18Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds
#923COSMETIC COMPOSITION COMPRISING HYDROPHILIC ANTIOXIDANTS AND THIOPYRIDINONE COMPOUNDS
#924EPIDERMAL STEM CELL PROLIFERATION-PROMOTING AGENT
#925MINOXIDIL ADJUVANT THERAPIES
#926COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF SWEAT MALODOR
#927COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER
#928PEPTIDE COMPOSITIONS AND METHODS FOR AMELIORATING SKIN LAXITY AND BODY CONTOUR
#929MELANIN HAIR DYE WITH THICKENERS
#930COMPOSITION FOR SKINCARE
#931 ✅ Patent 12,102,707 granted on 2024-10-01Skin care composition
#932Oral Care Compositions Comprising Ascorbic Acid Derivatives
#933TOPICAL SANITISING COMPOSITION COMPRISING MINIMAL AMOUNTS OF AN ANTIMICROBIAL LIPID
#934Enhanced Deposition Compositions For Personal Care Actives
#935Styling Shampoo Compositions
#936SKIN CARE EMULSION COMPOSITION WITH CLEAN POLYMERS AND EMULSIFIERS
#937SKIN CARE COMPOSITION WITH CLEAN POLYMER
#938TOOTH BRIGHTENING COMPOSITION, KIT, AND METHOD OF USING THE SAME
#939COSMETIC COMPOSITION COMPRISING A SILICONE, A STARCH AND AT LEAST 3% OF POLYOL, AND COSMETIC TREATMENT PROCESS
#940COSMETIC COMPOSITION COMPRISING MICA AND LAUROYL LYSINE
#941Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active
#942COMPOSITION FOR BLOCKING ULTRAVIOLET RAYS AND FINE DUST, AND PREPARATION METHOD THEREOF
#943PET FOOD COMPOSITIONS
#944AMMONIA OXIDIZING MICROORGANISMS FOR PH MODULATION
#945Antipsychotic Injectable Depot Composition
#946Monolithic Implantable Device for Sustained Release of an Antibody
#947Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And Trastuzumab
#948MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN
#949IMPLANTABLE CANNABIS TRANSDERMAL
#950DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF
#951COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
#952PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH VOLTAGE-GATED SODIUM CHANNELS
#953ORAL THIN FILM
#954RAPIDLY DISINTERGRATING COMPOSTIONS AND METHODS (Nicotine)
#955 ✅ Patent 12,042,559 granted on 2024-07-23Gastroretentive dosage forms for sustained drug delivery
#956RUXOLITINIB OR DEUTERATED RUXOLITINIB COMPOSITION AND USES THEREOF
#957 ✅ Patent 12,186,427 granted on 2025-01-07Fulvestrant formulations and methods of their use
#958INTRINSICALLY-DISORDERED PROTEINS AS EMULSIFIERS
#959MICROFLUIDIC PREPARATION OF FLUOROCARBON NANODROPLETS
#960LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE
#961MICROSPHERE FORMULATIONS COMPRISING BTK INHIBITORS AND METHODS FOR MAKING AND USING THE SAME
#962USE OF A GROWTH FACTORS-ENRICHED DRY POWDER FOR RELIEVING INFLAMMATION OR INJURY
#963 ✅ Patent 12,161,758 granted on 2024-12-10Modified release formulations and uses thereof
#964JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION
#965DELAYED RELEASE SOFTGEL CAPSULES
#966DELAYED RELEASE SOFTGEL CAPSULES
#967NANOCAPSULE AND USES THEREOF
#968Intradermal Delivery of Extracellular Vesicle-Encapsulated Curcumin Using Dissolvable Microneedle Arrays
#969 ✅ Patent 11,826,477 granted on 2023-11-28Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment
#970 ✅ Patent 12,280,158 granted on 2025-04-22Method for forming a nanomedicinal composition
#971 ✅ Patent 12,109,315 granted on 2024-10-08Method for treating Blastocystis infection
#972NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT
#973ON DEMAND AND LONG-TERM DRUG DELIVERY FROM DEGRADABLE NANOCAPSULES
#974DELIVERY SYSTEMS
#975INJECTABLE PREFORMED MACROSCOPIC 3-DIMENSIONAL SCAFFOLDS FOR MINIMALLY INVASIVE ADMINISTRATION
#976NOVEL DISINTEGRATION ORAL FILM FORMULATION WITH A CONTROLLED OR SUSTAINED ACTIVE RELEASE
#977 ✅ Patent 12,295,919 granted on 2025-05-13Methods of treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid
#978SOLID FORMS OF CANNABIDIOL AND USES THEREOF
#979INTOXICATION-REDUCING SUPPLEMENTAL MIXTURE
#980 ✅ Patent 11,872,196 granted on 2024-01-16Use of cannabidiol in treatment of pulmonary hypertension
#981 ✅ Patent 12,201,590 granted on 2025-01-21Extending human life with non-invasive mTOR inhibitor compositions
#982CANNABINOID DOSING REGIME FOR DERMATITIS AND INFLAMMATORY SKIN CONDITIONS
#983CANNABINOID ENCAPSULATION TECHNOLOGY
#984APPLICATION OF ALPHA-ASARONE IN PREPARATION OF MEDICINE FOR PREVENTING OR TREATING HEMORRHAGIC STROKE
#985USE OF (5R,7R,10R)-12,15-DIOXO-ALPHA-SELINENE IN THE PREPARATION OF DRUGS
#986COMPOSITIONS, METHODS OF TREATMENT, AND CONTAINERS INCLUDING COMPOSITIONS
#987ADMINISTRATION OF N,N-DIMETHYLACETAMIDE AND ITS MONOMETHYLATED METABOLITES FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#988METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#989SODIUM OXYBATE TO TREAT IDIOPATHIC HYPERSOMNIA
#990Pet Food Compositions
#991BHB LIPOSOMES AND PREPARATION METHODS THEREOF
#992COMPOUND FOR THE REDUCTION OF WHITE ADIPOSE TISSUE AND THE TREATMENT OF OVERWEIGHT AND OBESITY
#993MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#994USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE’S DISEASE, TOURETTE’S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION
#995THERAPEUTIC WINDOW FOR CITRULLINE THERAPY
#996Pet Food Compositions
#997AGENT FOR INHIBITING RENAL DAMAGE INDUCED BY RHABDOMYOLYSIS
#998TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D
#999 ✅ Patent 12,156,860 granted on 2024-12-03Disorders implicating PUFA oxidation
#1000OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
#1001ANTIMICROBIAL, DISINFECTING AND WOUND HEALING COMPOSITIONS AND METHODS FOR PRODUCING AND USING SAME
#1002COMBINATIONS OF METAP2 INHIBITORS AND CD4/6 INHIBITORS FOR THE TREATMENT OF CANCER
#1003COMBINATION FOR REDUCING OXIDATIVE STRESS IN THE BODY AND MAINTAINING LIVER FUNCTIONS
#1004TERPENE-BASED COMPOSITIONS, METHODS OF PREPARATIONS AND USES THEREOF
#1005ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING SLEEP DISORDERS
#1006METHODS TO SENSITIZE CANCER CELLS TO IMMUNE ATTACK USING ATRACTYLENOLIDE I
#1007Gamma Butyrolactone Derivatives for Inducing Differentiation in Neoplastic Cells
#1008COMPOSITIONS AND METHOD FOR EFFECTIVE MANAGEMENT OF PERITONITIS
#1009DIRECT DELIVERY OF VITAMINS TO REBALANCE GUT MICROBIOME AFTER EXPOSURE TO ANTIBIOTICS
#1010Combination Comprising Abemaciclib and 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylic Acid
#1011INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#1012NEW CARBAZOLE DERIVATIVES SENSITIZING CELLS TO ANTI-CANCER AGENTS
#1013 ✅ Patent 11,957,659 granted on 2024-04-16Transmucosal dephosphorylated psychoactive alkaloid composition and preparation thereof
#1014COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND
#1015PHARMACEUTICAL COMBINATION CONTAINING CAPSID PROTEIN INHIBITOR AND NUCLEOSIDE ANALOG
#1016MODULATORS OF GTPASES AND THEIR USE
#1017 ✅ Patent 12,171,749 granted on 2024-12-24Thioureylene liquid compositions
#1018ALPHA-2 ADRENERGIC RECEPTOR AGONISTS TO REDUCE MORTALITY AND IMPROVE OUTCOMES IN VIRAL RESPIRATORY SYNDROMES
#1019METHODS OF TREATING SPONDYLOARTHRITIS OR SYMPTOMS THEREOF
#1020PHARMACEUTICALLY ACTIVE COMPOUND FORMULATIONS
#1021USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#1022COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
#1023 ✅ Patent 11,951,100 granted on 2024-04-09Formulations of RBP4 inhibitors and methods of use
#1024METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS
#1025COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1 AND/OR PD-L1 INHIBITOR
#1026METHOD OF TREATING BREAST CANCER
#1027PROSTAGLANDIN RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF A CORONAVIRUS INFECTION SUCH AS COVID-19
#1028GRK2 INHIBITION BY PAROXETINE AMELIORATES OSTEOARTHRITIS
#1029NEUROPROTECTIVE CB2 RECEPTOR AGONISTS
#1030FIBROUS PELLET FOR ORAL APPLICATIONS AND METHODS THEREOF
#1031TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS
#1032 ✅ Patent 11,998,541 granted on 2024-06-04Method for alleviating chronic liver disease using Rosoxacin
#1033MARKERS OF TISSUE AGING AND USES THEREFOR
#1034COMPOSITIONS AND METHODS FOR TREATING PULMONARY FIBROSIS
#1035APPLICATION OF ISOQUINOLINE COMPOUND IN TUMOR TREATMENT
#1036COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER
#1037Combination Therapies for Treating Cancer
#1038COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
#1039TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME
#1040TREATMENT OR PREVENTION OF HIV INFECTION
#1041COMBINATIONS OF DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS AND ACETYL-COA CARBOXYLASE INHIBITOR
#1042APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS
#1043COMBINATION THERAPY OF DONEPEZIL AND TADALAFIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR COGNITIVE IMPAIRMENT
#1044TREATMENT OF GAIT DYSFUNCTION IN NEURODEGENERATIVE DISEASE
#1045COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD
#1046COMPOUND FOR USE IN AND METHODS OF TREATMENT OF FIBROTIC DISEASES
#1047TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH INHIBITORS OF MENIN
#1048METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES WITH AMINO-PYRROLOPYRIMIDINONE COMPOUNDS
#1049 ✅ Patent 12,233,068 granted on 2025-02-25Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)
#1050COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#1051IRAK4 DEGRADERS AND USES THEREOF
#1052 ✅ Patent 11,911,386 granted on 2024-02-27Methods of treating B-cell proliferative disorder
#1053USE OF AN IRAK4 MODULATOR FOR GENE THERAPY
#1054SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA
#1055HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS
#1056METHODS OF USING RHO KINASE INHIBITORS TO TREAT FRONTOTEMPORAL DEMENTIA
#1057FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS
#1058ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT
#1059SULFATED C19 STEROID HORMONES TO TREAT AND/OR PREVENT PROTEOTOXICITY IN PROTEIN-AGGREGATION DISEASES
#1060GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
#1061LIPID-LIKE NANOCOMPLEXES AND USES THEREOF
#1062USE OF THE NAV1.6 SODIUM CHANNEL BLOCKER (S)-4-((1-BENZYLPYRROLIDIN-3-YL)(METHYL)AMINO)-2-FLUORO-5-METHYL-N(THIAZOL-4-YL)BENZENESULFONAMIDE, TOGETHER WITH STRONG INDUCERS OF CYTOCHROME P450 3A4, IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH NAVI.6 ACTIVITY
#1063NOVEL NANO-FORMULATION OF CANNABIDIOL (CBD) AND OTHER CANNABINOIDS FOR TREATMENT OF OCULAR DISORDERS
#1064CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES
#1065A Method of Treating Depression by Immune Modulation
#1066INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS
#1067COMPOSITIONS FOR REDUCING INFLAMMATION TO IMPROVE OR MAINTAIN MENTAL OR PHYSICAL HEALTH
#1068 ✅ Patent 12,005,069 granted on 2024-06-11Bortezomib compositions
#1069TOPICAL COMPOSITIONS INCORPORATING SILICA FIBERS
#1070METHODS AND COMPOSITIONS RELATED TO RECEPTOR-MEDIATED GLUCOSE SENSING
#1071PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1072Therapeutic Agent for Progressive Disease Caused by Increase in Eomes-Positive CD4-Positive T Cells
#1073FORMULATION OF IVERMECTIN IN SOFT GELATIN CAPSULES
#1074MONTBRETIN A FUNCTIONAL FOOD
#1075A NEW STREPTOMYCES SPORORAVEUS STRAIN AND A NEW ANTIBIOTICS AGAINST BACTERIA AND FUNGI
#1076PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATING CANCER
#1077 ✅ Patent 12,016,877 granted on 2024-06-25Anticancer compositions and methods for making and using them
#1078miR-29a-LIKE NUCLEIC ACID REAGENT, LIVER FIBROSIS INHIBITOR, AND PHARMACEUTICAL COMPOSITION
#1079METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS
#1080 ✅ Patent 12,233,085 granted on 2025-02-25Application of hyaluronic acid in preparing medicines for preventing or treating ferroptosis-related diseases
#1081Compositions to Modify Intestinal Nutrient Absorption, Methods of Making and Uses Thereof
#1082PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
#1083ANTISEPTIC COMPOSITION
#1084 ✅ Patent 11,925,661 granted on 2024-03-12Ready-to-use potassium phosphates in sodium chloride solutions
#1085ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES
#1086Methods and compositions for eliminating engineered immune cells
#1087SYSTEM AND METHOD FOR COLD ATMOSPHERIC PLASMA BASED T CELL THERAPY
#1088 ✅ Patent 12,144,828 granted on 2024-11-19Human Kynureninase enzymes and uses thereof
#1089COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS
#1090PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS, COMPRISING, AS ACTIVE INGREDIENT, STEM CELLS HAVING EXPRESSION OF SPECIFIC GENES INCREASED OR DECREASED THEREIN
#1091PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS, COMPRISING ISOLATED MITOCHONDRIA
#1092ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS
#1093NOVEL NR1 ES-DERIVED NEURAL STEM CELLS HAVING A NORMAL KARYOTYPE AND USES THEREOF
#1094DEVELOPMENT OF AMNION-LIKE TISSUE FROM HUMAN PLURIPOTENT STEM CELLS
#1095Extraction Method of Natural Crocodile Oil and Extracted Crocodile Oil
#1096MEDICAL COMPOSITIONS AND THEIR USE IN TREATING INFLAMMATORY BOWEL DISEASE
#1097EXTRACELLULAR VESICLES FROM PREVOTELLA
#1098A MYCOBACTERIUM FOR USE IN CANCER THERAPY
#1099AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES
#1100COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME
#1101GOS PRE-CONDITIONING L. REUTERI AND GOS IN FINAL FORMULATION
#1102USE OF PROBIOTIC COMPONENT AND PHARMACEUTICAL COMPOSITION CONTAINING PROBIOTIC COMPONENT
#1103LACTOBACILLUS PLANTARUM BNT_G401 STRAIN AND USE THEREOF
#1104MODIFIED HTERT PROMOTER FOR REGULATING CANCER CELL-SPECIFIC GENE EXPRESSION AND ANTI-TUMOR ADENOVIRUS CONTAINING SAME
#1105 ✅ Patent 11,975,036 granted on 2024-05-07Methods of treating ovarian cancer with hemp extract
#1106ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS
#1107RADIATION-INDUCED FIBROSIS TREATMENT
#1108METHODS OF TREATING AND PREVENTING INFECTIONS OF CORONAVIRUS AND OTHER INDICATIONS, AND COMPOSITIONS FOR USE WITH SAME
#1109PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN INHIBITING IMMUNE RESPONSES
#1110COMPOSITIONS AND METHODS USEFUL FOR MANAGEMENT OF BLOOD SUGAR
#1111Texture-Controlled Fiber Ingredient Containing Viscous Soluble Fiber and Consumable Food and Fiber Supplement Products Incorporating Same
#1112Soft Chewable Compositions
#1113 ✅ Patent 12,285,455 granted on 2025-04-29Controlled-release and stratified cyclodextrin inclusion complex vehicles
#1114PREPARATIONS CONTAINING MITRAGYNE EXTRACT OR ITS ISOLATED ALKALOIDS AND CANNABIS EXTRACT OR ITS ISOLATED CANNABINOIDS, AND COSMETIC AND/OR PHARMACEUTICAL USE THEREOF
#1115COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT
#1116COMPOSITION FOR TREATING PAIN AND METHOD OF USE THEREOF
#1117DETECTION AND TREATMENT OF INTESTINAL FIBROSIS
#1118 ✅ Patent 12,128,083 granted on 2024-10-29Lisinopril formulations
#1119METHODS AND COMPOSITIONS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS
#1120PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE AS ACTIVE INGREDIENT
#1121METHODS FOR PREVENTING AND TREATING INTRA-ABDOMINAL CANDIDIASIS
#1122TREATMENT METHODS USING BOTULINUM TOXINS
#1123USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING INFLAMMATORY BOWEL DISEASE
#1124PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT
#1125COMPOSITIONS AND METHODS FOR PREVENTING, DETECTING, AND TREATING INFLAMMATORY BOWEL DISEASE
#1126ACYLATED GLP-1/GLP-2 DUAL AGONISTS
#1127Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists
#1128Heparin-Associated Polypeptides and Uses Thereof
#1129ANTIVIRAL AGENTS
#1130METHODS OF MODULATING GASTROINTESTINAL METABOLITES
#1131COMPOSITION FOR REGULATING OSTEOCLAST DIFFERENTIATION, AND USE THEREOF
#1132USE OF THERAPEUTIC ENZYME FUSION PROTEIN IN PREVENTION AND TREATMENT OF RENAL DISEASES CAUSED BY OR ACCOMPANIED BY FABRY DISEASE
#1133TREATMENT OR PREVENTION OF A DISEASE OR DISORDER
#1134DOSING REGIMEN
#1135ADAMTS13 VARIANT HAVING INCREASED ESCAPING RATE OR ACTIVITY AGAINST AUTOANTIBODY
#1136METHODS OF REDUCING COLLAGENASE-MEDIATED BRUISING IN A SUBJECT HAVING CELLULITE
#1137TYPE E BOTULINUM TOXIN TO TREAT BOTULISM
#1138 ✅ Patent 11,944,669 granted on 2024-04-02Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#1139VACCINE
#1140MOTIF NEOEPITOPES FOR CANCER IMMUNOTHERAPY
#1141NEOANTIGENS AND METHODS OF THEIR USE
#1142COXIELLA BURNETII AVIRULENT NINE MILE PHASE II VIABLE BACTERIA AND METHODS OF USE
#1143PROTEOGLYCAN CONJUGATE AND APPLICATION THEREOF
#1144COMBINATION OF A POXVIRUS ENCODING HPV POLYPEPTIDES WITH AN ANTI-PD-L1 ANTIBODY
#1145CHIMERIC PROTEIN COMPRISING THE RECEPTOR BINDING DOMAIN OF THE CORONA VIRUS SPIKE PROTEIN AND COMPOSITIONS COMPRISING THEM
#1146BUNYAVIRALES VACCINE
#1147PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)
#1148NUCLEIC ACIDS, PROTEINS, AND VACCINES OF SARS-COV-2
#1149Canine Parvovirus
#1150EBV-TARGETED ALLOGENEIC B CELL VACCINE AND PREPARATION METHOD THEREFOR
#1151PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMBINED FORMULATION, AND COMBINED FORMULATION KIT FOR PREVENTION OR TREATMENT OF CHRONIC HEPATITIS B, EACH COMPRISING, AS ACTIVE INGREDIENT, ORAL ANTIVIRAL AGENT AND THERAPEUTIC VACCINE INCLUDING LIPOPEPTIDE AND POLY(I:C) ADJUVANT
#1152SYSTEMS FOR BUCCAL RELEASE OF PROTEINS
#1153MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER
#1154COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A)
#1155VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#1156METHODS AND SYSTEMS FOR CLASSIFICATION AND TREATMENT OF SMALL CELL LUNG CANCER
#1157STAT-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF
#1158TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13RALPHA2 POSITIVE MALIGNANCIES
#1159ENGINEERED CELLULAR ADHESION MOLECULES AND METHODS OF USE THEREOF
#1160ENGINEERED IPSC AND IMMUNE EFFECTOR CELLS FOR HETEROGENOUS TUMOR CONTROL
#1161COMPOSITIONS AND USES OF PSCA TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS
#1162COMPOSITIONS OF NANOPARTICLES FOR TREATMENT OF CANCER
#1163GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
#1164TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL
#1165FORMULATIONS AND USES THEREOF
#1166Compositions for Enhancing Bioavailability of Pharmaceuticals, Supplements and Ingested Substances
#1167 ✅ Patent 12,226,486 granted on 2025-02-18Method for bowel preparation
#1168PROINFLAMMATORY PRODRUGS
#1169COMPOSITIONS AND METHODS FOR MODIFYING BACTERIAL GENE EXPRESSION
#1170COMPOSITION FOR TARGETING CANCER CELL, COMPRISING STRAIN EXPRESSING MONOMERIC STREPTAVIDIN, AND BIOTINYLATED COMPOUND
#1171ANTITUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOF
#1172PURIFIED MULTIVALENT PROTEIN-HYALURONIC ACID POLYMER CONJUGATES
#1173NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION
#1174THERAPEUTIC CONJUGATES
#1175New Combinations of Boron Compounds and Adjuvants for the Treatment of Pathophysiological Conditions and Cancer and for Muscle Regeneration
#1176Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#1177ANTI-CD79B ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#1178ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN ROR1 AND USE FOR THE SAME
#1179ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY
#1180ANTIBODY DRUG CONJUGATE
#1181PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE
#1182TYROSINE-BASED ANTIBODY CONJUGATES
#1183INDUCIBLE CELL DEATH SYSTEMS
#1184IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA
#1185Antibody-conjugated nanoparticles
#1186 ✅ Patent 12,016,931 granted on 2024-06-25Nanoparticles comprising peptides including an n-terminal linker
#1187GENE THERAPY FOR ALZHEIMER'S DISEASE
#1188GENE THERAPIES FOR NEURODEGENERATIVE DISEASE
#1189VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES
#1190USE OF IRAK4 MODULATORS FOR GENE THERAPY
#1191METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES
#1192FIBROBLAST ACTIVATION PROTEIN-TARGETED MAGNETIC RESONANCE IMAGING AGENTS, COMPOSITIONS, AND METHODS OF USE
#1193METHOD FOR PREPARING NANOPARTICLES
#1194NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG
#1195METHODS OF DIAGNOSING AND PROGNOSING CANCERS OF THE HEAD AND NECK
#1196MELANOCORTIN TYPE 2 RECEPTOR (MC2R) TARGETED THERAPEUTICS AND USES THEREOF
#1197SURFACE DISINFECTION WITH PR3+ DOPED INORGANIC PHOSPHORS
#1198METHOD OF STERILIZATION SPECIMEN CONDITIONING
#1199TABLETOP DUAL-CHAMBER STEAM STERILIZER WITH INTEGRATED WATER DISTILLER
#1200 ✅ Patent 12,115,267 granted on 2024-10-15Devices configured to disinfect interiors